1. Home
  2. WHWK vs IGI Comparison

WHWK vs IGI Comparison

Compare WHWK & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

179.8M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Investment Grade Defined Opportunity Trust Inc.

IGI

Western Asset Investment Grade Defined Opportunity Trust Inc.

N/A

Current Price

$16.29

Market Cap

97.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WHWK
IGI
Founded
2007
N/A
Country
United States
United States
Employees
22
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
179.8M
97.0M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
WHWK
IGI
Price
$3.92
$16.29
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
170.8K
10.1K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$15.78
52 Week High
$4.40
$17.09

Technical Indicators

Market Signals
Indicator
WHWK
IGI
Relative Strength Index (RSI) 62.91 58.85
Support Level $1.84 $16.33
Resistance Level $4.40 $16.60
Average True Range (ATR) 0.25 0.18
MACD 0.01 0.04
Stochastic Oscillator 99.36 81.82

Price Performance

Historical Comparison
WHWK
IGI

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

Share on Social Networks: